Arrêt de service lundi 11 juillet de 12h30 à 13h : tous les sites du CCSD (HAL, Epiciences, SciencesConf, AureHAL) seront inaccessibles (branchement réseau à modifier)
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Perminder S. Sachdev 1 Jessica W. Lo John D. Crawford Lisa Mellon Anne Hickey 2 David Williams 3 Régis Bordet 4 Anne-Marie Mendyk 4 Patrick Gelé 5 Dominique Deplanque 4 Hee-Joon Bae 1 Jae-Sung Lim 1 Amy Brodtmann Emilio Werden Toby Cumming Sebastian Köhler 6 Frans R. J. Verhey yan-Hong Dong Hui Hui Tan Christopher Chen Xu Xin 7 Raj N. Kalaria Louise M. Allan Rufus O. Akinyemi Adesola Ogunniyi 8 Aleksandra Klimkowicz-Mrowiec 9 Martin Dichgans 1 Frank A. Wollenweber Vera Zietemann 1 Michael Hoffmann 10 David W. Desmond Thomas Linden Christian Blomstrand Björn Fagerberg Ingmar Skoog 11 Olivier Godefroy 12, 13, 14 Mélanie Barbay 15 Martine Roussel 13 Byung-Chul Lee Kyung-Ho yu Joanna Wardlaw 16 Stephen J. Makin Fergus N. Doubal Francesca M. Chappell Velandai K. Srikanth Amanda G. Thrift Geoffrey A. Donnan Nagaendran Kandiah Russell J. Chander Xuling Lin Charlotte Cordonnier 4 Solene Moulin 4 Costanza Rossi 4 Behnam Sabayan 17 David J. Stott 1 J. Wouter Jukema 18 Susanna Melkas 19 Hanna Jokinen 20 Timo Erkinjuntti 21 Vincent C. T. Mok Adrian Wong Bonnie y. K. Lam Didier Leys 4 Hilde Hénon 4 Stéphanie Bombois 4 Darren M. Lipnicki Nicole A. Kochan 
Abstract : INTRODUCTION: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD). METHODS: Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia. RESULTS: Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years. DISCUSSION: Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03669043
Contributeur : Hélène ELEOUET Connectez-vous pour contacter le contributeur
Soumis le : lundi 16 mai 2022 - 12:11:05
Dernière modification le : vendredi 20 mai 2022 - 09:50:21

Lien texte intégral

Identifiants

Collections

Citation

Perminder S. Sachdev, Jessica W. Lo, John D. Crawford, Lisa Mellon, Anne Hickey, et al.. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.. Alzheimer's & dementia (Amsterdam, Netherlands), 2017, 7, pp.11--23. ⟨10.1016/j.dadm.2016.10.006⟩. ⟨hal-03669043⟩

Partager

Métriques

Consultations de la notice

8